SCHOTT Pharma AG & Co. KGaA (1SXP) - Total Liabilities

Latest as of September 2024: €650.00 Million EUR ≈ $759.92 Million USD

Based on the latest financial reports, SCHOTT Pharma AG & Co. KGaA (1SXP) has total liabilities worth €650.00 Million EUR (≈ $759.92 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SCHOTT Pharma AG & Co. KGaA (1SXP) net asset momentum to track the company's year-over-year net asset growth rate.

SCHOTT Pharma AG & Co. KGaA - Total Liabilities Trend (2020–2024)

This chart illustrates how SCHOTT Pharma AG & Co. KGaA's total liabilities have evolved over time, based on quarterly financial data. See SCHOTT Pharma AG & Co. KGaA (1SXP) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

SCHOTT Pharma AG & Co. KGaA Competitors by Total Liabilities

The table below lists competitors of SCHOTT Pharma AG & Co. KGaA ranked by their total liabilities.

Company	Country	Total Liabilities
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd SHE:000766	China	CN¥2.42 Billion
Aehr Test Systems NASDAQ:AEHR	USA	$18.25 Million
Coface SA PA:COFA	France	€5.87 Billion
Proximus NV BR:PROX	Belgium	€8.79 Billion
China Longyuan Power Group Corporation Limited F:6WX	Germany	€175.83 Billion
Hamilton Insurance Group, Ltd. NYSE:HG	USA	$7.11 Billion
Boise Cascad Llc NYSE:BCC	USA	$1.33 Billion
Diamondrock Hospitality Company Common Stock NASDAQ:DRH	USA	$1.56 Billion

Liability Composition Analysis (2020–2024)

This chart breaks down SCHOTT Pharma AG & Co. KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SCHOTT Pharma AG & Co. KGaA market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.82	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.45	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SCHOTT Pharma AG & Co. KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SCHOTT Pharma AG & Co. KGaA (2020–2024)

The table below shows the annual total liabilities of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024.

Year	Total Liabilities	Change
2024-06-30	€650.00 Million ≈ $759.92 Million	+20.45%
2023-06-30	€539.65 Million ≈ $630.91 Million	+10.71%
2022-06-30	€487.46 Million ≈ $569.89 Million	+52.10%
2021-06-30	€320.48 Million ≈ $374.67 Million	+14.31%
2020-06-30	€280.36 Million ≈ $327.77 Million	--

About SCHOTT Pharma AG & Co. KGaA

XETRA:1SXP Germany Medical Instruments & Supplies

Market Cap

$3.87 Billion

€3.31 Billion EUR

Market Cap Rank

#5500 Global

#874 in Germany

Share Price

€21.95

Change (1 day)

-0.23%

52-Week Range

€12.96 - €24.60

All Time High

€41.20